Cell cytotoxicity assays showed that in UBE2S-knockdown and MK2206-treated HCC cells, FOXM1 overexpression failed to rescue the suppression effects on chemoresistance (Fig. 5J–M). This evidence concerns the gene FOXM1 and hepatocellular carcinoma.